ANT-301

N/A

Report date: 2024/08/07 20:00:43

Base Information

Drug NameANT-301
Drug Alias NameANT-301
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnterogen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnterogen Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A